Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Hepatitis C virus NS5A protein increases hepatic lipid accumulation via induction of activation and expression of PPARgamma.

Kim K, Kim KH, Ha E, Park JY, Sakamoto N, Cheong J.

FEBS Lett. 2009 Sep 3;583(17):2720-6. doi: 10.1016/j.febslet.2009.07.034. Epub 2009 Jul 23.

2.

Liver X receptor α-mediated regulation of lipogenesis by core and NS5A proteins contributes to HCV-induced liver steatosis and HCV replication.

García-Mediavilla MV, Pisonero-Vaquero S, Lima-Cabello E, Benedicto I, Majano PL, Jorquera F, González-Gallego J, Sánchez-Campos S.

Lab Invest. 2012 Aug;92(8):1191-202. doi: 10.1038/labinvest.2012.88. Epub 2012 May 28.

3.

Positive correlation between PPARgamma/PGC-1alpha and gamma-GCS in lungs of rats and patients with chronic obstructive pulmonary disease.

Li J, Dai A, Hu R, Zhu L, Tan S.

Acta Biochim Biophys Sin (Shanghai). 2010 Sep;42(9):603-14. doi: 10.1093/abbs/gmq071. Epub 2010 Aug 7.

PMID:
20732852
4.

PPAR(gamma)/PGC-1(alpha) pathway in E-cadherin expression and motility of HepG2 cells.

Lee HJ, Su Y, Yin PH, Lee HC, Chi CW.

Anticancer Res. 2009 Dec;29(12):5057-63. Erratum in: Anticancer Res. 2010 Jan;30(1):277. Anticancer Res. 2010 Mar;30(3):1033.

5.

Gene expression of PPARgamma and PGC-1alpha in human omental and subcutaneous adipose tissues is related to insulin resistance markers and mediates beneficial effects of physical training.

Ruschke K, Fishbein L, Dietrich A, Klöting N, Tönjes A, Oberbach A, Fasshauer M, Jenkner J, Schön MR, Stumvoll M, Blüher M, Mantzoros CS.

Eur J Endocrinol. 2010 Mar;162(3):515-23. doi: 10.1530/EJE-09-0767. Epub 2009 Dec 4.

6.

Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma.

Kim KH, Shin HJ, Kim K, Choi HM, Rhee SH, Moon HB, Kim HH, Yang US, Yu DY, Cheong J.

Gastroenterology. 2007 May;132(5):1955-67. Epub 2007 Mar 24.

PMID:
17484888
7.

The metabolic regulator PGC-1α links hepatitis C virus infection to hepatic insulin resistance.

Shlomai A, Rechtman MM, Burdelova EO, Zilberberg A, Hoffman S, Solar I, Fishman S, Halpern Z, Sklan EH.

J Hepatol. 2012 Oct;57(4):867-73. doi: 10.1016/j.jhep.2012.06.021. Epub 2012 Jun 23.

PMID:
22732512
8.

HCV core protein induces hepatic lipid accumulation by activating SREBP1 and PPARgamma.

Kim KH, Hong SP, Kim K, Park MJ, Kim KJ, Cheong J.

Biochem Biophys Res Commun. 2007 Apr 20;355(4):883-8. Epub 2007 Feb 20.

PMID:
17331464
9.

Gene program-specific regulation of PGC-1{alpha} activity.

Schmidt SF, Mandrup S.

Genes Dev. 2011 Jul 15;25(14):1453-8. doi: 10.1101/gad.2076411.

10.

Structural and biochemical basis for the binding selectivity of peroxisome proliferator-activated receptor gamma to PGC-1alpha.

Li Y, Kovach A, Suino-Powell K, Martynowski D, Xu HE.

J Biol Chem. 2008 Jul 4;283(27):19132-9. doi: 10.1074/jbc.M802040200. Epub 2008 May 9.

11.

Peroxisome proliferator-activated receptor-γ cofactors in neurodegeneration.

Katsouri L, Blondrath K, Sastre M.

IUBMB Life. 2012 Dec;64(12):958-64. doi: 10.1002/iub.1097. Epub 2012 Nov 6. Review.

12.
13.

Tissue-specific regulation of metabolic pathways through the transcriptional coactivator PGC1-alpha.

Puigserver P.

Int J Obes (Lond). 2005 Mar;29 Suppl 1:S5-9. Review.

PMID:
15711583
14.

Peroxisome proliferator-activated receptor gamma and its coactivator-1 alpha may be associated with features of the metabolic syndrome in adolescents.

Sookoian S, García SI, Porto PI, Dieuzeide G, González CD, Pirola CJ.

J Mol Endocrinol. 2005 Oct;35(2):373-80.

PMID:
16216916
15.

Hepatitis C virus nonstructural protein 5A favors upregulation of gluconeogenic and lipogenic gene expression leading towards insulin resistance: a metabolic syndrome.

Parvaiz F, Manzoor S, Iqbal J, McRae S, Javed F, Ahmed QL, Waris G.

Arch Virol. 2014 May;159(5):1017-25. doi: 10.1007/s00705-013-1892-3. Epub 2013 Nov 16.

PMID:
24240483
16.

Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway.

Finck BN, Gropler MC, Chen Z, Leone TC, Croce MA, Harris TE, Lawrence JC Jr, Kelly DP.

Cell Metab. 2006 Sep;4(3):199-210.

17.

14-3-3β and γ differentially regulate peroxisome proliferator activated receptor γ2 transactivation and hepatic lipid metabolism.

Park S, Yoo S, Kim J, An HT, Kang M, Ko J.

Biochim Biophys Acta. 2015 Oct;1849(10):1237-47. doi: 10.1016/j.bbagrm.2015.08.002. Epub 2015 Aug 7.

PMID:
26260846
18.

Activation of nuclear receptor coactivator PGC-1alpha by arginine methylation.

Teyssier C, Ma H, Emter R, Kralli A, Stallcup MR.

Genes Dev. 2005 Jun 15;19(12):1466-73.

19.

Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1 alpha and PPAR beta/delta gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus.

Mensink M, Hesselink MK, Russell AP, Schaart G, Sels JP, Schrauwen P.

Int J Obes (Lond). 2007 Aug;31(8):1302-10. Epub 2007 Feb 20.

PMID:
17310221
20.

Effect of peroxisome proliferator-activated receptors-gamma and co-activator-1alpha genetic polymorphisms on plasma adiponectin levels and susceptibility of non-alcoholic fatty liver disease in Chinese people.

Hui Y, Yu-Yuan L, Yu-Qiang N, Wei-Hong S, Yan-Lei D, Xiao-Bo L, Yong-Jian Z.

Liver Int. 2008 Mar;28(3):385-92. Epub 2007 Nov 12. Erratum in: Liver Int. 2008 Feb;28(2):288.

PMID:
17999673

Supplemental Content

Support Center